152 related articles for article (PubMed ID: 35122358)
1. Antemortem basal forebrain atrophy in pure limbic TAR DNA-binding protein 43 pathology compared with pure Alzheimer pathology.
Teipel SJ; Grothe MJ;
Eur J Neurol; 2022 May; 29(5):1394-1401. PubMed ID: 35122358
[TBL] [Abstract][Full Text] [Related]
2. MRI-based basal forebrain atrophy and volumetric signatures associated with limbic TDP-43 compared to Alzheimer's disease pathology.
Teipel S; Grothe MJ;
Neurobiol Dis; 2023 May; 180():106070. PubMed ID: 36898615
[TBL] [Abstract][Full Text] [Related]
3. Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease.
Teipel SJ; Fritz HC; Grothe MJ;
Neurology; 2020 Sep; 95(10):e1301-e1311. PubMed ID: 32631924
[TBL] [Abstract][Full Text] [Related]
4. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
5. Independent and additive contribution of white matter hyperintensities and Alzheimer's disease pathology to basal forebrain cholinergic system degeneration.
Kindler C; Upadhyay N; Bendella Z; Dorn F; Keil VC; Petzold GC
Neuroimage Clin; 2023; 39():103477. PubMed ID: 37478584
[TBL] [Abstract][Full Text] [Related]
6. Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease.
Mohanty R; Ferreira D; Frerich S; Muehlboeck JS; Grothe MJ; Westman E;
Neurology; 2022 Jul; 99(4):e323-e333. PubMed ID: 35609990
[TBL] [Abstract][Full Text] [Related]
7. Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects.
Grothe MJ; Ewers M; Krause B; Heinsen H; Teipel SJ;
Alzheimers Dement; 2014 Oct; 10(5 Suppl):S344-53. PubMed ID: 24418052
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal Sclerosis but Not Normal Aging or Alzheimer Disease Is Associated With TDP-43 Pathology in the Basal Forebrain of Aged Persons.
Cykowski MD; Takei H; Van Eldik LJ; Schmitt FA; Jicha GA; Powell SZ; Nelson PT
J Neuropathol Exp Neurol; 2016 May; 75(5):397-407. PubMed ID: 26971127
[TBL] [Abstract][Full Text] [Related]
9. The cholinergic system in subtypes of Alzheimer's disease: an in vivo longitudinal MRI study.
Machado A; Ferreira D; Grothe MJ; Eyjolfsdottir H; Almqvist PM; Cavallin L; Lind G; Linderoth B; Seiger Å; Teipel S; Wahlberg LU; Wahlund LO; Westman E; Eriksdotter M;
Alzheimers Res Ther; 2020 May; 12(1):51. PubMed ID: 32375872
[TBL] [Abstract][Full Text] [Related]
10. Association of TDP-43 Pathology with Global and Regional 18F-Florbetapir PET Signal in the Alzheimer's Disease Spectrum.
Teipel SJ; Temp AGM; Levin F; Dyrba M; Grothe MJ;
J Alzheimers Dis; 2021; 79(2):663-670. PubMed ID: 33337372
[TBL] [Abstract][Full Text] [Related]
11. TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration.
Buciuc M; Martin PR; Tosakulwong N; Murray ME; Petrucelli L; Senjem ML; Spychalla AJ; Knopman DS; Boeve BF; Petersen RC; Parisi JE; Reichard RR; Dickson DW; Jack CR; Whitwell JL; Josephs KA
Neuroimage Clin; 2022; 34():102954. PubMed ID: 35168140
[TBL] [Abstract][Full Text] [Related]
12. Basal forebrain volume and metabolism in carriers of the Colombian mutation for autosomal dominant Alzheimer's disease.
Teipel S; Grazia A; Dyrba M; Grothe MJ; Pomara N
Sci Rep; 2024 May; 14(1):11268. PubMed ID: 38760448
[TBL] [Abstract][Full Text] [Related]
13. Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum.
Teipel SJ; Dyrba M; Ballarini T; Brosseron F; Bruno D; Buerger K; Cosma NC; Dechent P; Dobisch L; Düzel E; Ewers M; Fliessbach K; Haynes JD; Janowitz D; Kilimann I; Laske C; Maier F; Metzger CD; Munk MH; Peters O; Pomara N; Preis L; Priller J; Ramírez A; Roy N; Scheffler K; Schneider A; Schott BH; Spottke A; Spruth EJ; Wagner M; Wiltfang J; Jessen F; Heneka MT
J Alzheimers Dis; 2022; 85(3):1267-1282. PubMed ID: 34924387
[TBL] [Abstract][Full Text] [Related]
14. Subregional volume reduction of the cholinergic forebrain in subjective cognitive decline (SCD).
Scheef L; Grothe MJ; Koppara A; Daamen M; Boecker H; Biersack H; Schild HH; Wagner M; Teipel S; Jessen F
Neuroimage Clin; 2019; 21():101612. PubMed ID: 30555006
[TBL] [Abstract][Full Text] [Related]
15. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal Basal Forebrain Degeneration Interacts with TREM2/C3 Biomarkers of Inflammation in Presymptomatic Alzheimer's Disease.
Schmitz TW; Soreq H; Poirier J; Spreng RN
J Neurosci; 2020 Feb; 40(9):1931-1942. PubMed ID: 31915256
[TBL] [Abstract][Full Text] [Related]
17. Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson's disease.
Schumacher J; Kanel P; Dyrba M; Storch A; Bohnen NI; Teipel S; Grothe MJ
Brain; 2023 Dec; 146(12):4964-4973. PubMed ID: 37403733
[TBL] [Abstract][Full Text] [Related]
18. TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia.
Sahoo A; Bejanin A; Murray ME; Tosakulwong N; Weigand SD; Serie AM; Senjem ML; Machulda MM; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Dickson DW; Whitwell JL; Josephs KA
J Alzheimers Dis; 2018; 64(4):1227-1233. PubMed ID: 30010126
[TBL] [Abstract][Full Text] [Related]
19. The basal forebrain volume reduction detected by MRI does not necessarily link with the cholinergic neuronal loss in the Alzheimer's disease mouse model.
Zhou XA; Ngiam G; Qian L; Sankorrakul K; Coulson EJ; Chuang KH
Neurobiol Aging; 2022 Sep; 117():24-32. PubMed ID: 35640461
[TBL] [Abstract][Full Text] [Related]
20. Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease.
de Flores R; Wisse LEM; Das SR; Xie L; McMillan CT; Trojanowski JQ; Robinson JL; Grossman M; Lee E; Irwin DJ; Yushkevich PA; Wolk DA
Alzheimers Dement; 2020 Jun; 16(6):843-852. PubMed ID: 32323446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
